Basic Overview of Preclinical Toxicology in Drug Development
•Repeat Dose Toxicity •Extensive evaluations of toxic effects •Body weights •Clinical signs of toxicity •Food consumption •Clinical pathology •Histopathology •Other •Large animals usually undergo more extensive evaluation (e.g.,ECGs) •At least one dose should produce dose-limiting toxicity. •At least one dose should be non ... ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- does high dose intravenous acetaminophen affect liver
- highlights of prescribing information hepatotoxicity has
- basic overview of preclinical toxicology in drug development
- toxicity of local anesthetics world health organization
- acute acetaminophen toxicity in adults
- safety considerations in phase 1 trials umd
- transcriptome and metabolome analysis of liver and kidneys
- pasture associated liver disease in horses1
- early onset 5 fluorouracil toxicity clinical indicators
- skin manifestations of liver diseases
Related searches
- overview of starbucks
- starbucks overview of the company
- overview of photosynthesis
- overview of photosynthesis quizlet
- activity overview of photosynthesis
- preclinical toxicology studies
- preclinical studies in drug development
- preclinical to clinical drug development
- stages of drug development pharmaceutical
- generic drug development process
- overview of the book of acts
- preclinical toxicology testing services